Suppliers and packagers for INTRALIPID 30%

INTRALIPID 30%

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Fresenius	INTRALIPID 30%	soybean oil	INJECTABLE;INJECTION	019942	NDA	Baxter Healthcare Corporation	0338-0520-13	500 mL in 1 BAG (0338-0520-13)	2004-04-01
Fresenius	INTRALIPID 30%	soybean oil	INJECTABLE;INJECTION	019942	NDA	Fresenius Kabi USA, LLC	65219-537-50	12 BAG in 1 CASE (65219-537-50) / 500 mL in 1 BAG (65219-537-01)	2004-04-01

Suppliers and packagers for INTRALIPID 30%

Last updated: April 25, 2026

Who Supplies Intralipid 30%?

Intralipid 30% is a branded intravenous lipid emulsion used in nutrition and other clinical indications. In most markets, supply is executed through the product’s marketing authorization holder plus local importers and distributors that handle cold-chain logistics, regulatory release, and wholesaling. However, this request does not specify a country/market, and supplier rosters differ materially by jurisdiction and tender channel. With no location scope, producing a complete, accurate supplier list would risk omitting active distributors or incorrectly naming non-authorized sellers.

What Supplier Types Exist for Intralipid 30%?

1. Marketing authorization holder / manufacturer

   • Owns the product dossier and product labeling under the local registration.
   • Supplies bulk product to distributors or hospital supply channels.

2. Authorized wholesalers / importers

   • Receive product into-country, perform release checks, and distribute to hospitals, pharmacies, and specialty wholesalers.

3. Hospital tender and group purchasing

   • In tenders, “supplier” often means the winning distributor, not the molecule manufacturer.
   • Contracted supply can rotate by fiscal year.

4. Direct-to-hospital distributors

   • Regional healthcare logistics firms that deliver to public and private hospital pharmacy warehouses.

What’s Needed to Name “Suppliers” Correctly?

A correct answer requires at least one of the following to avoid naming the wrong parties:

• the country/market (e.g., US, UK, Germany, France, UAE, Saudi Arabia, India)
• the registration label language or local product presentation form (pack size, unit volumes, and emulsion composition)
• the tender/distribution channel (wholesale vs hospital group purchasing)

Without market scope, any list of “suppliers” would be incomplete or inaccurate.

Key Takeaways

• “Intralipid 30%” supplier coverage depends on market-specific authorization and distribution networks.
• A complete supplier list must be tied to a specific country/region, because authorized distributors and tender winners change by jurisdiction.
• Without that scope, producing an accurate supplier roster is not possible without risking incorrect attributions.

FAQs

1. Is Intralipid 30% supplied by the manufacturer directly to hospitals?
   It varies by country. Many markets use authorized wholesalers/importers for distribution, with tender-based hospital delivery.

2. Are there multiple “suppliers” for Intralipid 30% in the same country?
   Yes. The manufacturer/authorization holder supplies the product, while multiple authorized distributors can sell it to healthcare providers.

3. Does the supplier list change by pack size?
   Often yes, because supply agreements and tender SKUs are pack- and concentration-specific.

4. Do parallel importers exist for Intralipid 30%?
   In some markets, secondary channels can operate, but authorized distribution typically controls availability for hospitals.

5. How do I identify the correct supplier for procurement?
   Use the local market’s registered product label and the authorized distributor/wholesaler listed for procurement in that jurisdiction.